PubRank

Margaret M Esiri

Author PubWeight™ 63.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2007 5.27
2 Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002 2.20
3 Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage 2011 1.88
4 Estimated neuronal populations and volumes of the hippocampus and its subfields in schizophrenia. Am J Psychiatry 2002 1.74
5 Axonal injury in cerebral malaria. Am J Pathol 2002 1.65
6 Asymmetry of the uncinate fasciculus: a post-mortem study of normal subjects and patients with schizophrenia. Cereb Cortex 2002 1.53
7 Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis 2011 1.52
8 Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry 2002 1.52
9 T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. Immunity 2009 1.50
10 Haplotype-specific expression of exon 10 at the human MAPT locus. Hum Mol Genet 2006 1.47
11 Absence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritis. J Neurol Sci 2003 1.42
12 TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype. Acta Neuropathol 2011 1.32
13 A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 2006 1.23
14 A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology. Brain 2012 1.22
15 Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol 2010 1.15
16 Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol 2006 1.13
17 Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease. J Neurosci Res 2010 1.13
18 Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol Psychiatry 2002 1.12
19 IL-21 and IL-21 receptor expression in lymphocytes and neurons in multiple sclerosis brain. Am J Pathol 2011 1.11
20 Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat 2007 1.08
21 Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol 2006 1.07
22 Spinal cord neuronal pathology in multiple sclerosis. Brain Pathol 2008 1.01
23 Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. Br J Psychiatry 2006 0.99
24 Spinal cord atrophy in multiple sclerosis caused by white matter volume loss. Arch Neurol 2005 0.98
25 Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 2005 0.95
26 Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 2003 0.94
27 Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease. Cereb Cortex 2011 0.91
28 The neuropathology of vascular disease in the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Curr Alzheimer Res 2012 0.91
29 Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. J Neural Transm (Vienna) 2008 0.91
30 Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia. BMC Neurol 2007 0.90
31 Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing. Acta Neuropathol 2006 0.89
32 Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett 2008 0.89
33 Concurrent multiple sclerosis and amyotrophic lateral sclerosis: where inflammation and neurodegeneration meet? J Neuroinflammation 2012 0.88
34 Macroscopic brain asymmetry is changed along the antero-posterior axis in schizophrenia. Schizophr Res 2005 0.87
35 Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain 2014 0.87
36 Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. J Cereb Blood Flow Metab 2013 0.86
37 Brain burdens of aluminum, iron, and copper and their relationships with amyloid-β pathology in 60 human brains. J Alzheimers Dis 2012 0.86
38 Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease. Neurobiol Aging 2005 0.86
39 Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions. J Neuroimmunol 2012 0.85
40 Association between subcortical vascular disease on CT and neuropathological findings. Int J Geriatr Psychiatry 2004 0.85
41 Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease. Neurobiol Dis 2006 0.84
42 Prefrontal cortex cytoarchitecture in normal aging and Alzheimer's disease: a relationship with IQ. Brain Struct Funct 2012 0.84
43 Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochem Int 2011 0.83
44 Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease. Neuroreport 2002 0.83
45 Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology. Brain 2013 0.82
46 Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia. Neuroreport 2010 0.82
47 Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. Neurochem Int 2010 0.82
48 Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease. Acta Neuropathol Commun 2013 0.82
49 Ventricular enlargement in schizophrenia: a primary change in the temporal lobe? Schizophr Res 2003 0.82
50 Low medial and lateral right pulvinar volumes in schizophrenia: a postmortem study. Am J Psychiatry 2003 0.81
51 Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease. Psychopharmacology (Berl) 2010 0.79
52 Pathological validation of a CT-based scale for subcortical vascular disease. The OPTIMA Study. Dement Geriatr Cogn Disord 2004 0.77
53 Tau phosphorylation in human brain: relationship to behavioral disturbance in dementia. Neurobiol Aging 2012 0.77
54 Serotonin transporters are preserved in the neocortex of anxious Alzheimer's disease patients. Neuroreport 2003 0.76
55 The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis. Neuropathol Appl Neurobiol 2015 0.76
56 Subventricular zone cytoarchitecture changes in autism. Dev Neurobiol 2013 0.76
57 Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease. Clin Cancer Res 2004 0.76
58 White matter damage in dementia. Introduction. Brain Pathol 2015 0.75
59 Optic neuropathy in superficial intracranial siderosis. J Neuroophthalmol 2010 0.75